Long non‑coding RNA MALAT1 suppresses the proliferation and migration of endothelial progenitor cells in deep vein thrombosis by regulating the Wnt/β‑catenin pathway

Du,Binghui; Wang,Jian; Zang,Sheng; Mao,Xin; Du,Yaming

doi:10.3892/etm.2020.9066

Long non‑coding RNA MALAT1 suppresses the proliferation and migration of endothelial progenitor cells in deep vein thrombosis by regulating the Wnt/β‑catenin pathway

Authors:
- Binghui Du
- Jian Wang
- Sheng Zang
- Xin Mao
- Yaming Du
View Affiliations

Affiliations: Department of Vascular Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China
Published online on: July 28, 2020 https://doi.org/10.3892/etm.2020.9066
Pages: 3138-3146
Copyright: © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Deep vein thrombosis (DVT) is one of the most common circulating vascular diseases with an incidence of ~0.1% worldwide. Although anticoagulant medication remains to be the main therapeutic approach for patients with DVT, existing thrombus and pulmonary embolisms still pose as a threat to patient life. Therefore, effective targeted therapies need to be developed and studies are required to improve understanding of this condition. Endothelial progenitor cells (EPCs) originate from the bone marrow, are located in the peripheral blood and are involved in thrombus resolution. Long non‑coding RNAs (lncRNAs) are non‑coding RNAs that are >200 nucleotides in length. LncRNAs are associated with the development of numerous vascular diseases. Among these lncRNAs, metastasis associated lung adenocarcinoma transcript 1 (MALAT1) is downregulated in human atherosclerotic plaques. Furthermore, MALAT1 polymorphism resulted in vascular disease in Chinese populations. In the present study, the expression profile and potential functions of MALAT1 in DVT were investigated. The results revealed that MALAT1 was upregulated in DVT tissues. Furthermore, MALAT1 was able to regulate the biological behaviors of EPCs, including proliferation, migration, cell cycle arrest and apoptosis. In addition, the Wnt/β‑catenin signaling pathway is a promising downstream target of MALAT1 in DVT. The changes in biological behaviors in EPCs caused by silenced MALAT1 were reversed by inhibition of the Wnt/β‑catenin signaling pathway. In summary, the data indicated the roles of MALAT1 in the pathogenesis of DVT, and the MALAT1/Wnt/β‑catenin axis could be a novel therapeutic target for the treatment of DVT.

View Figures

View References

1	Sáez-Giménez B, Berastegui C, Loor K, López-Meseguer M, Monforte V, Bravo C, Santamaría A and Roman A: Deep vein thrombosis and pulmonary embolism after solid organ transplantation: An unresolved problem. Transplant Rev (Orlando). 29:85–92. 2015.PubMed/NCBI View Article : Google Scholar
2	Weitz JI, Eikelboom JW and Samama MM: New antithrombotic drugs: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 141 (Suppl 2):e120S–e151S. 2012.PubMed/NCBI View Article : Google Scholar
3	Bakogiannis C, Tousoulis D, Androulakis E, Briasoulis A, Papageorgiou N, Vogiatzi G, Kampoli AM, Charakida M, Siasos G, Latsios G, et al: Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes. Curr Med Chem. 19:2597–2604. 2012.PubMed/NCBI View Article : Google Scholar
4	Li W and Li X: Endothelial progenitor cells accelerate the resolution of deep vein thrombosis. Vascul Pharmacol. 83:10–16. 2016.PubMed/NCBI View Article : Google Scholar
5	Modarai B, Burnand KG, Sawyer B and Smith A: Endothelial progenitor cells are recruited into resolving venous thrombi. Circulation. 111:2645–2653. 2005.PubMed/NCBI View Article : Google Scholar
6	Wang W, Li C, Li W, Kong L, Qian A, Hu N, Meng Q and Li X: MiR-150 enhances the motility of EPCs in vitro and promotes EPCs homing and thrombus resolving in vivo. Thromb Res. 133:590–598. 2014.PubMed/NCBI View Article : Google Scholar
7	Hsiao J, Yuan TY, Tsai MS, Lu CY, Lin YC, Lee ML, Lin SW, Chang FC, Liu Pimentel H, Olive C, et al: Upregulation of haploinsufficient gene expression in the brain by targeting a long non-coding RNA improves seizure phenotype in a model of Dravet syndrome. EBioMedicine. 9:257–277. 2016.PubMed/NCBI View Article : Google Scholar
8	Holdt LM, Sass K, Gabel G, Bergert H, Thiery J and Teupser D: Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis. 214:264–270. 2011.PubMed/NCBI View Article : Google Scholar
9	Ballantyne M, Pinel K, Dakin R, Vesey A, Diver L, Mackenzie R, Garcia R, Welsh P, Sattar N, Hamilton G, et al: Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation. Circulation. 133:2050–2065. 2016.PubMed/NCBI View Article : Google Scholar
10	Sallam T, Jones M, Thomas BJ, Wu X, Gilliland T, Qian K, Eskin A, Casero D, Zhang Z, Sandhu J, et al: Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA. Nat Med. 24:304–312. 2018.PubMed/NCBI View Article : Google Scholar
11	Boulberdaa M, Scott E, Ballantyne M, Garcia R, Descamps B, Angelini GD, Brittan M, Hunter A, McBride M, McClure J, et al: A role for the long noncoding RNA SENCR in commitment and function of endothelial cells. Mol Ther. 24:978–990. 2016.PubMed/NCBI View Article : Google Scholar
12	Ishii N, Ozaki K, Sato H, Mizuno H, Saito S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, et al: Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet. 51:1087–1099. 2006.PubMed/NCBI View Article : Google Scholar
13	Vausort M, Wagner DR and Devaux Y: Long noncoding RNAs in patients with acute myocardial infarction. Circ Res. 115:668–677. 2014.PubMed/NCBI View Article : Google Scholar
14	Arslan S, Berkan Ö, Lalem T, Özbilüm N, Göksel S, Korkmaz Ö, Çetin N and Devaux Y: Cardiolinc^™ network. Long non-coding RNAs in the atherosclerotic plaque. Atherosclerosis. 266:176–181. 2017.PubMed/NCBI View Article : Google Scholar
15	Zhuo Y, Zeng Q, Zhang P, Li G, Xie Q and Cheng Y: Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people. Clin Chem Lab Med. 55:38–46. 2017.PubMed/NCBI View Article : Google Scholar
16	Hermans KC and Blankesteijn WM: Wnt signaling in cardiac disease. Compr Physiol. 5:1183–1209. 2015.PubMed/NCBI View Article : Google Scholar
17	Zhao Y, Wang C, Wang C, Hong X, Miao J, Liao Y, Zhou L and Liu Y: An essential role for Wnt/β-catenin signaling in mediating hypertensive heart disease. Sci Rep. 8(8996)2018.PubMed/NCBI View Article : Google Scholar
18	Cohen ED, Tian Y and Morrisey EE: Wnt signaling: An essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development. 135:789–798. 2008.PubMed/NCBI View Article : Google Scholar
19	Gay A and Towler DA: Wnt signaling in cardiovascular disease: Opportunities and challenges. Curr Opin Lipidol. 28:387–396. 2017.PubMed/NCBI View Article : Google Scholar
20	Nayak G, Odaka Y, Prasad V, Solano AF, Yeo EJ, Vemaraju S, Molkentin JD, Trumpp A, Williams B, Rao S and Lang RN: Developmental vascular regression is regulated by a Wnt/β-catenin, MYC and CDKN1A pathway that controls cell proliferation and cell death. Development. 145: pii(dev154898)2018.PubMed/NCBI View Article : Google Scholar
21	Du Y, Zhang S, Yu T, Du G, Zhang H and Yin Z: Wnt3a is critical for endothelial progenitor cell-mediated neural stem cell proliferation and differentiation. Mol Med Rep. 14:2473–2482. 2016.PubMed/NCBI View Article : Google Scholar
22	Guo C and Wang X, Chen LP, Li M, Li M, Hu YH, Ding WH and Wang X: Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 22:3703–3712. 2018.PubMed/NCBI View Article : Google Scholar
23	Li GQ, Fang YX, Liu Y, Meng FR, Wu X, Zhang CW, Zhang Y, Liu D and Gao B: MALAT1-driven inhibition of Wnt signal impedes proliferation and inflammation in fibroblast-like synoviocytes through CTNNB1 promoter methylation in rheumatoid arthritis. Hum Gene Ther. 30:1008–1022. 2019.PubMed/NCBI View Article : Google Scholar
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
25	Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y and Yang K: Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 34(7)2015.PubMed/NCBI View Article : Google Scholar
26	Cheng Y, Imanirad P, Jutooru I, Hedrick E, Jin UH, Rodrigues Hoffman A, Leal de Araujo J, Morpurgo B, Golovko A and Safe S: Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer. PLoS One. 13(e0192264)2018.PubMed/NCBI View Article : Google Scholar
27	Xu Y, Zhang X, Hu X, Zhou W, Zhang P, Zhang J, Yang S and Liu Y: The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9. Mol Med. 24(52)2018.PubMed/NCBI View Article : Google Scholar
28	Ling J, Wang F, Liu C, Dong X, Xue Y, Jia X, Song W and Li Q: FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling. J Exp Clin Cancer Res. 38(179)2019.PubMed/NCBI View Article : Google Scholar
29	Zhou W, He X, Chen Z, Fan D, Wang Y, Feng H, Zhang G, Lu A and Xiao L: LncRNA HOTAIR-mediated Wnt/β-catenin network modeling to predict and validate therapeutic targets for cartilage damage. BMC Bioinformatics. 20(412)2019.PubMed/NCBI View Article : Google Scholar
30	Li C, Zheng X, Han Y, Lv Y, Lan F and Zhao J: XAV939 inhibits the proliferation and migration of lung adenocarcinoma A549 cells through the WNT pathway. Oncol Lett. 15:8973–8982. 2018.PubMed/NCBI View Article : Google Scholar
31	Bilir B, Kucuk O and Moreno C: Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med. 11(280)2013.PubMed/NCBI View Article : Google Scholar
32	Bao R, Christova T, Song S, Angers S, Yan X and Attisano L: Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells. PLoS One. 7(e48670)2012.PubMed/NCBI View Article : Google Scholar